Isopathic therapy for aminoglycoside sensorineural hearing loss and deafness
AUTHORS : Abakarov1 M.G. | Gotovsky2 M.Yu. | Belousov1 Yu.B. | Magomedov3 MM.
RELEVANT UNIVERSITIES : 1Department of Clinical Pharmacology, GOU VPO Russian State Medical University, Moscow, 2Center
for Intelligent Medical Systems IMEDIS, Moscow, 3Department of Otorhinolaryngology, Faculty of
General Medicine, FUV GOU VPO “Russian State Medical University” Roszdrav, Moscow
YEAR : 2008
The aim of this controlled clinical trial is to evaluatethe effectiveness of isopathic therapy
for ototoxic sensorineural hearing loss with potentiated aminoglycosides.
The treatment was carried out at 46 people with chronic ototoxic sensorineural hearing loss of
severe degree (3-4 degrees) and deafness. Age from 19 to 58 years old, disease duration from 18 to 40
years. Potentiated aminoglycosides were used in potencies C3, C6, C12, C30 and C50. The drugs,
potencies and the regimen of administration were selected individually in accordance with the anamnesis
and the results of the electropuncture vegetative resonance test.
